-
<![CDATA[AstraZeneca Invests $2 Billion to Expand Biologics Manufacturing Footprint in Maryland]]>
24 Nov 2025 23:37 GMT
… of Americas supply operations at AstraZeneca. “The expansion underscores our … on branded or patented pharmaceutical products.
References
1. AstraZeneca Plans $2 Billion … .com/view/astrazeneca-expands-texas-manufacturing-facility-double …
-
AstraZeneca Shares Leap 9% as Pharma Giant Secures Breakthrough Cancer Drug Approval in UK Market
24 Nov 2025 10:11 GMT
… a diversified portfolio of AstraZeneca premiums against patent cliffs, with Enhertu being … finesse of the Chancellor, the AstraZeneca takeover increases the pressure on … UK).
The technical advantage of AstraZeneca peaks: machine learning platforms can …
-
With launch of Toothpod, U of T startup star shifts from winning awards to fighting plaque
25 Nov 2025 13:26 GMT
… and Michael Cloutier, a former AstraZeneca Canada president.
U of T … company has received a provisional patent and is now pursuing clinical …
-
DoP mulls exemption of 84 more drugs from public procurement rules that restrict global tender
25 Nov 2025 06:34 GMT
… 84 more drug formulations including patented and proprietary products, medicines yet … inhaler, and onasemnogene abeparvovee, and patented drugs including Merck's … eosinophilic asthma drug Fasenra from AstraZeneca, shingles vaccine Shingrix from Glaxo …
-
Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During the Forecast Period (2025-2034) Owing to the Launch of Novel GLP-2 Analogues | DelveInsight
24 Nov 2025 23:22 GMT
… . However, with GATTEX's patents expiring in the U.S … , Abivax, Roche, Telavant, Mesoblast, Takeda, AstraZeneca, among others.
About DelveInsight
DelveInsight …
-
IonQ Appoints Dr. Marco Pistoia as CEO of IonQ Italia
24 Nov 2025 17:07 GMT
… by the U.S. Patent and Trademark Office as one of the … such as Amazon Web Services, AstraZeneca, and NVIDIA achieve 20x performance …
-
Top 10 Indian Startups Powering Healthcare with AI
24 Nov 2025 17:12 GMT
… ) approved, and SigTuple holds multiple patents on its AI-based screening … lives, partnering with organisations like AstraZeneca to scale in underserved regions …
-
Generic Injectables Market to Reach US $234.33 Billion by 2029
24 Nov 2025 10:45 GMT
… . Factors such as cost-effectiveness, patent expirations, initiatives to improve healthcare … :
• Baxter International Inc.
• Sanofi SA
• AstraZeneca plc.
• Fresenius Medical Care AG …
-
Generic Oncology Drugs Market is Projected to Increase at a CAGR of 6.6% Through 2025-2029
24 Nov 2025 10:45 GMT
… such as the expiry of patents, cost containment in healthcare, rising … AG
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• Abbott Laboratories
• Fresenius Kabi …
-
Extended-Release Drugs Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights
24 Nov 2025 09:30 GMT
… of chronic diseases, improved efficacy, patent protection strategies, and biodegradable implants … AG
• Sanofi SA
• GlaxoSmithKline PLC
• AstraZeneca Plc
• Gilead Sciences Inc.
• Boehringer …